abstract |
The present invention describes methods for inhibiting angiogenesis in tissues using vitronectin alpha v beta 3 antagonists, and particularly for inhibiting angiogenesis in inflamed tissues and in tumor tissues and metastases using therapeutic compositions containing alpha v beta 3 antagonists. |